NCT07096778
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07096778
Title Inobrodib, Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma (DoMMino-1)
Acronym DoMMino-1
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors CellCentric Ltd.
Indications
Therapies
Age Groups: senior | adult
Covered Countries GBR

Facility Status City State Zip Country Details
Royal Marsden NHS Foundation Trust RECRUITING Sutton London SM2 5PT United Kingdom Details
Imperial College Healthcare NHS Trust, Hammersmith Hospital RECRUITING London W12 0HS United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field